OpenURL Connection Search

Select item for more details and to access through your institution.

Initial Australian experience with the atypical antipsychotic clozapine.
Published in:
1993
By:
- Keks, Nicholas A;
- Copolov, David L;
- Johnson, Gordon;
- Keks, N A;
- Copolov, D L;
- Johnson, G
Publication type:
Case Study
Assessment of cognitive function in heart failure patients.
Published in:
2006
By:
- Wolfe R;
- Worrall-Carter L;
- Foister K;
- Keks N;
- Howe V
Publication type:
Journal Article
Minimizing the non-extrapyramidal side-effects of antipsychotics.
Published in:
Acta Psychiatrica Scandinavica, 1996, v. 94, p. 18, doi. 10.1111/j.1600-0447.1996.tb05944.x
By:
- Keks, N. A.
Publication type:
Article
The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia.
Published in:
Acta Psychiatrica Scandinavica, 1994, v. 90, n. 5, p. 358, doi. 10.1111/j.1600-0447.1994.tb01607.x
By:
- Keks, N.;
- McGrath, J.;
- Lambert, T.;
- Catts, S.;
- Vaddadi, K.;
- Burrows, G.;
- Varghese, F.;
- George, T.;
- Hustig, H.;
- Burnett, P.;
- Kerr, K.;
- Zorbas, A.;
- Hill, C.;
- Stedman, T.;
- Johnson, G.;
- Leibert, B.;
- Copolov, D.;
- Mackenzie, M.;
- Dillenbeck, C.
Publication type:
Article
Comparison of participants and nonparticipants in a neuroendocrine investigation of psychosis.
Published in:
Acta Psychiatrica Scandinavica, 1991, v. 83, n. 5, p. 373, doi. 10.1111/j.1600-0447.1991.tb05558.x
By:
- Keks, N. A.;
- Copolov, D. L.;
- Mackie, B.;
- Stuart, G. W.;
- Singh, B. S.;
- McGorry, P. D.;
- Coffey, C.
Publication type:
Article
Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
Published in:
Acta Psychiatrica Scandinavica, 1990, v. 82, n. 4, p. 271, doi. 10.1111/j.1600-0447.1990.tb01383.x
By:
- Kulkarni, J.;
- Keks, N. A.;
- Stuart, G.;
- Mackie, B.;
- Minas, I. H.;
- Singh, B. S.;
- Copolov, D. L.
Publication type:
Article
Remoxipride Versus Thioridazine in the Treatment of First Episodes of Schizophrenia in Drug-Naive Patients: A Case for Specific, Low Potency D<sub>2</sub> Antagonists.
Published in:
Human Psychopharmacology: Clinical & Experimental, 1995, v. 10, n. 6, p. 455, doi. 10.1002/hup.470100604
By:
- Lambert, T.;
- Keks, N.;
- McGrath, J.;
- Catts, S.;
- Hustig, H.;
- Vaddadi, K.;
- Burrows, G.;
- Varghese, F.;
- George, T.;
- Kerr, K.;
- Johnson, G.;
- Burnett, P.;
- Zorbas, A.;
- Hill, C.;
- Copolov, D.
Publication type:
Article

Found: 7

Initial Australian experience with the atypical antipsychotic clozapine.

Assessment of cognitive function in heart failure patients.

Minimizing the non-extrapyramidal side-effects of antipsychotics.

The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia.

Comparison of participants and nonparticipants in a neuroendocrine investigation of psychosis.

Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.

Remoxipride Versus Thioridazine in the Treatment of First Episodes of Schizophrenia in Drug-Naive Patients: A Case for Specific, Low Potency D<sub>2</sub> Antagonists.